Collaboration agreement for drug discoveryCollaboration Agreement • September 11th, 2024
Contract Type FiledSeptember 11th, 2024The expanded agreement, signed in May 2019, extends the partnership to discover and design therapeutic compounds leveraging Schrödinger’s industry-leading computational platform.
Collaboration AgreementCollaboration Agreement • June 14th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledJune 14th, 2019 Company Industry JurisdictionThis COLLABORATION AGREEMENT (“Agreement”), dated as of June 10, 2015, is made by and between Morphic Rock Therapeutic, Inc. (“Client”), a Delaware corporation with offices at 1000 Winter Street, Suite 3350, Waltham, MA 02451 and SCHRÖDINGER, LLC (“Schrödinger”), a Delaware limited liability company, with offices at 120 West 45th Street, 17th Floor, New York, New York 10036.
Collaboration AgreementCollaboration Agreement • May 30th, 2019 • Morphic Holding, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 30th, 2019 Company Industry JurisdictionThis COLLABORATION AGREEMENT (“Agreement”), dated as of June 10, 2015, is made by and between Morphic Rock Therapeutic, Inc. (“Client”), a Delaware corporation with offices at 1000 Winter Street, Suite 3350, Waltham, MA 02451 and SCHRÖDINGER, LLC (“Schrödinger”), a Delaware limited liability company, with offices at 120 West 45th Street, 17th Floor, New York, New York 10036.